[Recurrence of hepatocellular carcinoma and its treatment].
Komechi
H
H
Tutui
H
H
Aramaki
T
T
Ohoya
T
T
Kumazaki
T
T
D000970:Antineoplastic Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic; D000431:Ethanol / Q000008:administration & dosage; D006526:Hepatitis C / Q000150:complications / Q000628:therapy; D006801:Humans; D015552:Injections, Intralesional; D016898:Interferon-alpha / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000628:therapy*
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D016898:Interferon-alpha; D000431:Ethanol